GGrantIndex
Sort

39,280 grants matching leukemia

Cancer and Leukemia Group B

$1,580,095
Richard L Schilsky · University Of Chicago · U10 · FY2008 · CA

Cancer and Leukemia Group B

$1,578,848
University Of Chicago · U10 · FY2004 · CA

INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA

$1,578,437
Beth Israel Deaconess Medical Center · P01 · FY2005 · CA

Protein Structure

$1,577,338
Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Hematopoietic Stem Cells for Transplantation

$1,576,651
Johns Hopkins University · P01 · FY2005 · CA

Children's Oncology Group

$1,576,321
Todd A Alonzo · University Of Southern California · U10 · FY2023 · CA

Clinical Research Support for the CCR

$1,576,085
Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2009 · CA

HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients

$1,575,472
Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2020 · HL

PAARK4Kids-Pharmacogenomics of Anticancer Agents Research in Children

$1,575,077
Mary V. Relling · St. Jude Children'S Research Hospital · U01 · FY2011 · GM

Development of Innovative Resources to Advance MDS Research

$1,574,993
Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2025 · DK

Development of Innovative Resources to Advance MDS Research

$1,574,980
Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2023 · DK

Identifying the spectrum of genetic alterations in high risk ALL

$1,573,220
Charles G. Mullighan · St. Jude Children'S Research Hospital · RC4 · FY2010 · CA

Clinical Research Correlatives Core

$1,572,539
Kaska Wloka · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Development of Gleevec for TB and TB/HIV

$1,571,205
Daniel Kalman · Emory University · UH3 · FY2019 · AI

Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders

$1,570,973
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

Family Studies

$1,570,700
Mary McMaster · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

Etiology of Treatment Induced Secondary Leukemia

$1,570,439
University Of Chicago · P01 · FY2003 · CA

BMT Survivor Study-2 (BMTSS-2)

$1,569,615
Smita Bhatia · University Of Alabama At Birmingham · U01 · FY2020 · CA

Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort

$1,567,792
Garnet L. Anderson · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA

Genome-Wide Association Study of Childhood Leukemia by Hispanic Status

$1,566,078
Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2011 · CA

HEMATOPOIETIC STEM CELLS FOR TRANSPLANTATION

$1,565,574
Johns Hopkins University · P01 · FY2001 · CA

NOVEL RAC PATHWAY INHIBITORS FOR THE TREATMENT OF METASTATIC RAS/MAPK ACTIVATED LEUKEMIA

$1,564,751
Childrens Hospital Medical Center · · FY2025 · Defense Health Agency

PAAR4Kids-Pharmacogenomics of Anticancer Agents Research in Children

$1,563,234
Mary V. Relling · St. Jude Children'S Research Hospital · U01 · FY2012 · GM

IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action

$1,563,132
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system

$1,563,132
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL